Early Expression of Interest for LSARP 2017

(Genomics and Precision health)

Purpose

The purpose of Genome Atlantic’s (GA) early Expression of Interest (eEOI) is to gauge early interest and help jumpstart the process of preparing teams for Genome Canada’s LSARP 2017 launch.Please note that submitting an eEOI to Genome Atlantic is necessary for participation in the whiteboard sessions.

Genome Canada’s LSARP funding program is highly competitive. Starting this process early will allow us to give teams access to strategic consultants to help to develop strong, impactful proposals, as well as identify sources of co-funding and potential collaborators. Please see the list of previously funded projects.

Please return forms to Kristin Tweel () or Britta Fiander () by December 12, 2016.

anticipated Timeline (subject to change)

Deadline foreEOIs to GA:December 12, 2016
Genome Canada RFA Announcement: January 2017
Genome Atlantic Whiteboard sessions for teams: Early February 2017
Registrations due to Genome Canada: March2017
Pre-Application Internal / Pre-submission Reviews: February - April 2017
Pre-Application Submission to Genome Canada: May 2017

  1. GENERAL PROJECT INFORMATION

PROJECT TITLE:
ACADEMIC PROJECT LEADER / CO-LEADER (If identified)

Name

/

Name

Affiliation

/

Affiliation

Telephone

/

Telephone

E-mail

/

E-mail

  1. Have you (or anyone on your team) discussed this project with your local health authority or ministry? (i.e. Nova Scotia Health Authority, Vitalité Health Network, Horizon Health Network, Eastern Health Authority, etc….)

Yes ☐No ☐

If you answered Yes, please indicate who you spoke with and their response.

  1. Have you confirmed that your project is aligned with your institution’s strategic research priorities?

Yes ☐No ☐

If you answered Yes, please indicate who you spoke with and relevant strategic area.

  1. If your team is currently not pan-Canadian in scope, would you be interested in exploring collaborations with other teams across the country?

Yes ☐No ☐

  1. Suggest one or two suitable external subject matter expert reviewers who could provide feedback on the draft application.
  1. Confirm availability of key research team members during the following weeks to enable scheduling of strategic reviewer workshops.

Week of / Available / Unavailable / Reason (i.e. vacation)
Jan 30 – Feb 3, 2017 / ☐ / ☐ /
Feb 6 – 10, 2017 / ☐ / ☐ /
Feb 13 – 17, 2017 / ☐ / ☐ /
  1. summary of the project

In a maximum two pages, provide a brief summary of the proposed research including half a page on the anticipatedintegrated GE3LS[1](definition) research component. Describe the deliverables expected at the end of the project and the social and/or economic benefits anticipated from their subsequent practical application.[2]

Project Summary (1 page)

Integrated GE3LS (1/2 page)

Deliverables & Socio-Economic Impact (1/2 page)

  1. project TEAM

Using the table below, please provide the details for key members of the team including end-users (hospital, SME, etc). Add rows if necessary.

Last Name / First Name / Affiliation / Role
  1. Total Budget and co-Funding Summary

Using the table below, please estimate total project budget and potential sources of co-funding.

Estimated Project Budget:
(between $2 - $10M)
PROJECT FUNDING SOURCES
Genome Canada Contribution (up to 33%):
SOURCES OF CO-FUNDING / CONTRIBUTION / Cash/In-kind(please indicate)
1.
2.
3.
4.

[1] GE3LS - Genomics and its Ethical, Environmental, Economic, Legal, and Social Aspects

[2] Additional general guidance information is at